Clinical Trial Update: Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is investigating ramatroban in addition to standard of care for hospitalized COVID-19 pneumonia patients; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia
• COVID-19 Respiratory Infection

Drugs mentioned

• Ramatroban (ramatroban)

Snippet

Sponsor: KARE Biosciences | Conditions: COVID-19 Pneumonia, COVID-19 Respiratory Infection | Phase 2, Phase 3 | Status: RECRUITING